Keren M Adler

4PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 12, 2025
The H3 K36M oncohistone inhibits NSD2 to activate a SETD2-dependent antiviral-like immune response in KRAS-driven lung cancer.

Amy C Gladstein, Carson D Poltorack, Akino Mercy Charles Solomon

|Jan 27, 2025
Tumor suppressor genotype influences the extent and mode of immunosurveillance in lung cancer.

Keren M Adler, Haiqing Xu, Amy C Gladstein

|Jul 21, 2023
p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism.

Jonuelle Acosta, Qinglan Li, Nelson F Freeburg

Pageof 1